CBir1 (flagellin) Ab in serum
Jump to navigation
Jump to search
Indications
- evaluation of Crohn's disease
Clinical significance
- anti-CBir antibody may be associated with Crohn's disease
More general terms
Additional terms
References
- ↑ Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, Lerner A, Weishauss O, Spector L, Shtevi A, Altstock RT, Dotan N, Halpern Z. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology. 2006 Aug;131(2):366-78. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16890590
- ↑ Papadakis KA, Yang H, Ippoliti A Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations. Inflamm Bowel Dis. 2007 May;13(5):524-30. PMID: https://www.ncbi.nlm.nih.gov/pubmed/17260364